IP and Technology2018-10-12T09:04:48+00:00

IP and Technology

CIMON Medical have exclusive commercial rights to proprietary technology relating to the monitoring of blood flow in patients using ultrasound. There are many clinical situations in which it is helpful to monitor blood flow in patients. CIMON Medical is licensing the following patents pending:

  • PCT/GB2017/052309 Ultrasound Blood-Flow Monitoring (core technology)
  • 3 Ultrasound Blood-Flow Monitoring (core technology)
  • 7 Ultrasound Blood-Flow Monitoring (neonatal monitoring)
  • 7 Ultrasound Blood-Flow Monitoring (sepsis diagnosis)
  • 9 Ultrasound Blood-Flow Monitoring (diabetes monitoring)

The CIMON Medical core technology consists of an ultrasound transducer and a controller subsystem. The transducer transmits plane-wave pulses into the tissue in a propagation direction, and measures reflections of the pulses as they echo back from within the tissue to generate Doppler response signals. It then processes these signals to estimate a measure that is proportional to the total blood volume flow passing through a certain region. The CIMON Medical ultrasound transducer is a single-element transducer, and the same element in the ultrasound transducer both transmits and receives ultrasound. This allows the cost of the transducer to be kept low, enabling disposable transducers. Depth is determined by the duration of each pulse, and by the time delay at which the reflections are sampled, and range gating may be used to control the depth that is being measured, creating a more complete picture of the tissue being monitored.

CIMON Medical’s innovation is the realization that relative measures of blood volume flow within a region can be obtained at much lower cost than an absolute measure, but be just as valuable. This circumvents the problem that has stumped previous attempts at continuous blood flow monitoring: attempting to establish an absolute measure in a single blood vessel. CIMON Medical’s solution settles to be proportional to the total blood volume flow, and can therefore use a low-cost, unfocused ultrasound transducer to monitor blood flow through a region of tissue. This means that there is no need for expensive transducers, complex processing systems, or skilled operators.

Technology stack

IP and Technology

CIMON Medical have exclusive commercial rights to proprietary technology relating to the monitoring of blood flow in patients using ultrasound. There are many clinical situations in which it is helpful to monitor blood flow in patients. CIMON Medical is licensing the following patents pending:

  • PCT/GB2017/052309 Ultrasound Blood-Flow Monitoring (core technology)
  • 3 Ultrasound Blood-Flow Monitoring (core technology)
  • 7 Ultrasound Blood-Flow Monitoring (neonatal monitoring)
  • 7 Ultrasound Blood-Flow Monitoring (sepsis diagnosis)
  • 9 Ultrasound Blood-Flow Monitoring (diabetes monitoring)

The CIMON Medical core technology consists of an ultrasound transducer and a controller subsystem. The transducer transmits plane-wave pulses into the tissue in a propagation direction, and measures reflections of the pulses as they echo back from within the tissue to generate Doppler response signals. It then processes these signals to estimate a measure that is proportional to the total blood volume flow passing through a certain region. The CIMON Medical ultrasound transducer is a single-element transducer, and the same element in the ultrasound transducer both transmits and receives ultrasound. This allows the cost of the transducer to be kept low, enabling disposable transducers. Depth is determined by the duration of each pulse, and by the time delay at which the reflections are sampled, and range gating may be used to control the depth that is being measured, creating a more complete picture of the tissue being monitored.

CIMON Medical’s innovation is the realization that relative measures of blood volume flow within a region can be obtained at much lower cost than an absolute measure, but be just as valuable. This circumvents the problem that has stumped previous attempts at continuous blood flow monitoring: attempting to establish an absolute measure in a single blood vessel. CIMON Medical’s solution settles to be proportional to the total blood volume flow, and can therefore use a low-cost, unfocused ultrasound transducer to monitor blood flow through a region of tissue. This means that there is no need for expensive transducers, complex processing systems, or skilled operators.

Technology stack